The National Association of Chain Drug Stores (NACDS) is working with the U.S. House of Representatives to support pharmacists' role in a new pilot program to advance medication therapy management (MTM) for Medicare patients. Read More »
Zoll Manufacturing Corporation's LifeVest wearable defibrillator was approved by the Food and Drug Administration (FDA) Dec. 17 for children at risk of sudden cardiac arrest. Read More »
The Kroger Co. acquired Roundy Inc.’s outstanding shares of common stock for $3.60 per share in cash Dec. 17. Read More »
Health care benefits company Aetna recently entered into an agreement with Abington Medical Specialists/AMS Cardiology to provide individuals with quality care at an affordable cost. Read More »
A clinical trial to assess the safety and effectiveness of an oral therapy to treat acute myeloid leukemia (AML) recently produced new data. Read More »
Independent chain Benzer Pharmacy opened a new location in Ormond Beach, Florida on Wednesday. Read More »
Wholly-owned subsidiary of Advanzeon Solutions, Pharmacy Value Management Solutions (PVMS), signed an agreement Dec. 18 with Arcadian Telepsychiatry. Read More »
In the next eight years, pharmacists’ employment is only expected to grow 3 percent in the United States, according to the Bureau of Labor Statistics. Read More »
The Fenix Continence Restoration System was approved by the U.S. Food and Drug Administration Dec. 18. Read More »
The Squarekids subcutaneous injection syringe was launched by Daiichi Sankyo, Japan Vaccine Company and Sanofi K.K. Dec. 9. Read More »
The Utilization Review Accreditation Commission (URAC) granted Diplomat Pharmacy full specialty pharmacy reaccreditation Dec. 17. Read More »
Kimberly Bartholomew was recently named the new GRx Hawaii regional account executive by Guaranteed Returns. Read More »
AlliancePharma Inc. launched Elitex, the first virtual schedule manager of its kind to be designed specifically for pharmacies, Wednesday. Read More »
In response to the U.S. Senate Special Committee on Aging's hearing on "Sudden Price Spikes in Off-Patent Prescription Drugs" held earlier this month, Pharmaceutical Care Management Association (PCMA) President and CEO Mark Merritt asked policymakers to take an initiative toward making generic drugs easier to produce and distribute. Read More »
Recent laboratory analysis conducted by the Food and Drug Administration (FDA) confirms that the herbal weight loss dietary supplement La’Trim Plus contains undeclared controlled substance sibutramine and chemical phenolphthalein. Read More »
Galapagos NV and Gilead Sciences Inc. entered into an international coalition Dec. 17 to develop and commercialize the JAK1-selective inhibitor filgotinib for inflammatory disease indications. Read More »
New Hampshire’s Department of Health and Human Services (DHHS) and Rite Aid signed a standing order Monday to stock naloxone, an emergency treatment drug for opiate overdoses. Read More »
While the Biosimilars Council, a division of the Generic Pharmaceutical Association (GPhA), applauds the Food and Drug Administration's (FDA) current discussions on the next Biosimilar User Fee Act (BsUFA), it hopes to collaborate even more with the FDA on biosimilar medications. Read More »
The Food and Drug Administration (FDA) granted approval Monday for Uptravi, a new oral IP prostacyclin receptor agonist medication to treat adults with pulmonary arterial hypertension (PAH). Read More »
The International Pharmaceutical Federation (FIP) published a guide Dec. 16, highlighting the significant role pharmacists can play in reducing tobacco use. Read More »
Alerts Sign-up
